4 Liver Cancer Clinical Trials in Buffalo, NY (2026)

Q: How do I join a clinical trial in Buffalo?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Buffalo research site will contact you.

Recruiting Liver Cancer Studies in Buffalo

NCT05168163Recruiting

Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer

This phase II trial tests whether atezolizumab in combination with a multi-kinase inhibitor (cabozantinib or lenvatinib) compared to multi-kinase inhibitor alone in treating patients with liver cancer...

Buffalo, NYPHASE2122 participantsAcademic and Community Cancer Research United

View Study Details

NCT04864054Recruiting

T-Cell Therapy (ECT204) in Adults With Advanced HCC

This is an open-label, dose escalation, multi-center, Phase I/II clinical trial aimed at assessing the safety and preliminary efficacy of an investigational ARTEMIS® ECT204 T-cell therapy. The trial i...

Buffalo, NYPHASE160 participantsEureka Therapeutics Inc.

View Study Details

NCT05733598Recruiting

Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC

The purpose of this study is to assess the efficacy and safety of RP2 in combination with atezolizumab plus bevacizumab in the second line setting for locally advanced unresectable, recurrent, and/or ...

Buffalo, NYPHASE260 participantsReplimune Inc.

View Study Details

NCT06728410Recruiting

A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement

This is a single arm phase II study of pemigatinib and durvalumab combination in patients with FGFR-2 fusion or rearrangement positive intrahepatic cholangiocarcinoma. Each cycle will be 3 weeks. Pemi...

Buffalo, NYPHASE238 participantsMehmet Akce

View Study Details

About Liver Cancer Clinical Trials in Buffalo

Liver cancer most commonly presents as hepatocellular carcinoma (HCC) and is often associated with chronic liver disease or hepatitis. It is one of the fastest-growing causes of cancer death. Treatment options include surgery, liver transplant, ablation, and systemic therapies.

There are currently 4 liver cancer clinical trials recruiting participants in Buffalo, NY. These studies are seeking a combined 280 participants. Research is being sponsored by Academic and Community Cancer Research United, Eureka Therapeutics Inc., Replimune Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Liver Cancer Clinical Trials in Buffalo — FAQ

Are there liver cancer clinical trials in Buffalo?

Yes, there are 4 liver cancer clinical trials currently recruiting in Buffalo, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Buffalo?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Buffalo research site will contact you about next steps.

Are clinical trials in Buffalo free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Buffalo studies also compensate for your time and travel.

What liver cancer treatments are being tested?

The 4 active trials in Buffalo are testing new therapies including novel drugs, biologics, and treatment approaches for liver cancer.

Data updated July 17, 2026 from ClinicalTrials.gov